Correlations of hippocampal atrophy and focal low-frequency magnetic activity in Alzheimer disease: volumetric MR imaging-magnetoencephalographic study.

BACKGROUND AND PURPOSE Patients with Alzheimer disease (AD) have more low-frequency activity on conventional EEG and increased focal magnetoencephalographic (MEG) dipole density (DD) in delta and theta bands. This activity concurs with atrophy and reduced metabolic and perfusion rates, particularly in temporoparietal structures. The relationship between functional and structural measures and their conjoined capability to improve the diagnosis of AD were assessed in this study. METHODS Whole-head MEG recordings were obtained in 15 patients in whom the diagnosis of AD had been made and in 16 healthy control subjects during a resting condition. MR imaging volumetric data were also obtained; these included global cerebral, temporal lobe, and hippocampal volumes. RESULTS DD in the delta and theta bands was enhanced in the AD group compared with the healthy control subjects. Slow-wave activity differed significantly between the groups in the temporoparietal regions of both hemispheres. Left hippocampal volume was correlated with left temporal and parietal delta DD and left temporal theta DD. A combination of left hippocampal volume and left temporal theta DD enabled correct classification in 87.1% of the patients with AD or control subjects. CONCLUSION Results support the predominant role of temporoparietal hypofunction as defined by DD and hippocampal structural deficits shown on MR images in patients with AD. A multidisciplinary perspective of different techniques may improve our understanding of the disease and our diagnostic abilities.

[1]  I Kanno,et al.  Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type. , 1997, Electroencephalography and clinical neurophysiology.

[2]  M. Bobinski,et al.  Hippocampal atrophy in early Alzheimer's Disease: Anatomic specificity and validation , 2005, Psychiatric Quarterly.

[3]  A. Burns,et al.  Single photon emission tomography in dementia , 1991 .

[4]  Thomas Dierks,et al.  Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease , 2000, Clinical Neurophysiology.

[5]  T. Ohnishi,et al.  Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process? , 2001, AJNR. American journal of neuroradiology.

[6]  J. Cummings,et al.  Sensitivity, Specificity, and Positive Predictive Value of Technetium 99-HMPAO SPECT in Discriminating Alzheimer's Disease from other Dementias , 1997, Journal of geriatric psychiatry and neurology.

[7]  G. Walstra,et al.  Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography , 1995, Journal of Neurology.

[8]  H. Soininen,et al.  Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. , 1999, AJNR. American journal of neuroradiology.

[9]  S Lehéricy,et al.  Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. , 1994, AJNR. American journal of neuroradiology.

[10]  W. Jagust,et al.  Clinical Studies of Cerebral Blood Flow in Alzheimer's Disease , 1997, Annals of the New York Academy of Sciences.

[11]  K. Meguro,et al.  Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[12]  Nick C Fox,et al.  Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. , 2001, AJNR. American journal of neuroradiology.

[13]  W. Jagust,et al.  Brain perfusion imaging predicts survival in Alzheimer's disease , 1998, Neurology.

[14]  H Sattel,et al.  [Volumetric brain changes and quantitative EEG in normal aging and Alzheimer's dementia]. , 1996, Der Nervenarzt.

[15]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions , 1995, Journal of neural transmission. Parkinson's disease and dementia section.

[16]  B. Reisberg Functional assessment staging (FAST). , 1988, Psychopharmacology bulletin.

[17]  B. W van Dijk,et al.  Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot study , 2000, Clinical Neurophysiology.

[18]  M J Bronskill,et al.  Quantitative MR volumetry in Alzheimer's disease , 1997, Neurology.

[19]  Barry Horwitz,et al.  Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type , 1995, Psychiatry Research.

[20]  A. Convit,et al.  Hippocampal volume losses in minimally impaired elderly , 1995, The Lancet.

[21]  M. Roth CAMDEX : the Cambridge examination for mental disorders of the elderly , 1999 .

[22]  R. Killiany,et al.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.

[23]  B. Rockstroh,et al.  Source distribution of neuromagnetic slow waves and MEG-delta activity in schizophrenic patients , 2001, Biological Psychiatry.

[24]  Rapoport Si,et al.  Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. , 1991 .

[25]  W. Jagust,et al.  The diagnosis of dementia with single photon emission computed tomography. , 1987, Archives of neurology.

[26]  E. Mori,et al.  Medial temporal structures relate to memory impairment in Alzheimer’s disease: an MRI volumetric study , 1997, Journal of neurology, neurosurgery, and psychiatry.

[27]  C. Breathnach Magnetism in medicine. , 1983, Irish medical journal.

[28]  D. Neary,et al.  Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[29]  S. Rapoport,et al.  Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. , 1991, Cerebrovascular and brain metabolism reviews.

[30]  Stephen A. Dyer,et al.  Digital signal processing , 2018, 8th International Multitopic Conference, 2004. Proceedings of INMIC 2004..

[31]  E. Jonkman,et al.  The role of the electroencephalogram in the diagnosis of dementia of the Alzheimer type: an attempt at technology assessment , 1997, Neurophysiologie Clinique/Clinical Neurophysiology.

[32]  L. Bour,et al.  Determinants of Quantitative Spectral Electroencephalography in Early Alzheimer’s Disease: Cognitive Function, Regional Cerebral Blood Flow, and Computed Tomography , 2000, Dementia and Geriatric Cognitive Disorders.

[33]  D. Amaral,et al.  Hippocampal‐neocortical interaction: A hierarchy of associativity , 2000, Hippocampus.

[34]  H J Testa,et al.  A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? , 1998, Journal of neurology, neurosurgery, and psychiatry.

[35]  M. Matousek,et al.  EEG abnormalities in dementia reflect the parietal lobe syndrome , 2001, Clinical Neurophysiology.

[36]  R. Woods,et al.  Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. , 2001, Cerebral cortex.

[37]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[38]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.